Since 2015, NeuroSys has been developing medical apps and software systems in the form of highly compatible, interoperable doctor-patient communication systems for the therapy monitoring of chronic diseases and mobile, digital applications for the medical sector. Our mHealth applications meet all the requirements for use in medical practice and medical research.
NeuroSys GmbH, based in Ulm, Germany, emerged in 2015 from the successful collaboration between NeuroPoint Gesellschaft für vorbeugende Gesundheitspflege GmbH and Systemhaus Ulm GmbH, an Ulm-based IT services company with extensive specialist knowledge in the field of innovative software development. The goal of NeuroSys is the development of adaptive, mobile mHealth applications, with the support of which the communication between doctors and their patients can be intensified and which should contribute to the improvement of the care situation in the health sector.
NeuroSys develops native Android and iOS applications with backend solutions for health applications in medical practice and medical research. Our apps meet the highest quality standards for medical software. The technical documentation of our software is carried out in accordance with the EU Medical Device Regulation (MDR). Our apps meet the requirements for CE conformity according to the quality management specification DIN EN ISO 13485 and are registered as class I active medical devices according to Directive 93/42/EEC.